Impact of monocytic differentiation on acute myeloid leukemia patients treated with venetoclax and hypomethylating agents.
Dian JinJingsong HeHaoguang ChenWenjun WuXiaoyan HanJing LeWenxiu ShuQianqian YangShanshan PeiZhen CaiDonghua HePublished in: Cancer medicine (2024)
Our study suggested that newly diagnosed AML with a monocytic immunophenotype had a poor prognosis with VEN/HMA treatment.